VPS13C^Halo-△(ATG2C-PH)
(Plasmid
#232867)
-
PurposeExpresses VPS13C-△(ATG2C-PH) in mammalian cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 232867 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameVPS13C-△(ATG2C-PH)
-
SpeciesH. sapiens (human)
-
Entrez GeneVPS13C (a.k.a. BLTP5C, PARK23)
-
Tag
/ Fusion Protein
- internal Halo
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2024.06.08.598070 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
VPS13C^Halo-△(ATG2C-PH) was a gift from Pietro De Camilli (Addgene plasmid # 232867 ; http://n2t.net/addgene:232867 ; RRID:Addgene_232867) -
For your References section:
The bridge-like lipid transport protein VPS13C/PARK23 mediates ER-lysosome contacts following lysosome damage. Wang X, Xu P, Bentley-DeSousa A, Hancock-Cerutti W, Cai S, Johnson BT, Tonelli F, Shao L, Talaia G, Alessi DR, Ferguson SM, De Camilli P. Nat Cell Biol. 2025 May;27(5):776-789. doi: 10.1038/s41556-025-01653-6. Epub 2025 Apr 10. 10.1038/s41556-025-01653-6 PubMed 40211074